Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for VTRLY and 80,000+ other tickers.
See exactly how VTRLY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for VTRLY and 80,000+ other tickers.
Vitrolife AB (publ) is a Swedish medical technology company, established in 1994 and headquartered in Gothenburg. Its core business involves the development, manufacturing, and distribution of specialized products catering to assisted reproductive technologies (ART). The company offers a comprehensive portfolio that includes essential tools for the in vitro fertilization (IVF) process, such as oocyte retrieval needles, solutions for sperm preparation, and advanced IVF culture media and oils. Beyond these, Vitrolife supplies a range of laboratory necessities like micromanipulation pipettes…
Vitrolife AB (publ) (VTRLY) Q2 2026 Earnings Call Transcript
The Annual General Meeting of Vitrolife AB (publ) was held today on Tuesday 5 May 2026. The Annual General Meeting resolved in accordance with all proposals presented by the Board and the Nomination Committee.
Vitrolife AB (publ) (VTRLY) Q1 2026 Earnings Call Transcript
GOTHENBURG, Sweden, April 23, 2026 /PRNewswire/ -- First quarter Sales of SEK 807 (842) million, an increase of 5% in local currencies and 4% decrease in SEK. Sales per region, in local currencies, were -1% in EMEA, +11% in Americas and +7% in APAC.
GOTHENBURG, Sweden, April 1, 2026 /PRNewswire/ -- The Annual General Meeting of Vitrolife AB (publ), 556354-3452, will be held on Tuesday 5 May 2026 at 17:00 CEST at Elite Park Avenue Hotel, Kungsportsavenyn 36-38 in Gothenburg, Sweden. Registration for the Annual General Meeting will commence at 16:30 CEST.